CAPN3 rs557164942: Understanding This Rare Genetic Variant

What each genotype means

What is rs557164942 and Where is it Located?

The variant rs557164942 is a single nucleotide polymorphism (SNP) situated on chromosome 15. Specifically, it resides within the CAPN3 gene, which provides instructions for producing an enzyme called calpain-3. In genetic databases, this variant is tracked as a change in the DNA sequence that can alter the function of the resulting protein. Because it is a rare variant, it is not commonly found in the general population. Geneticists study such variants to understand how specific changes in the DNA code can impact biological processes. When a variant is identified in a gene like CAPN3, researchers look at its position to determine if it disrupts the normal production or activity of the protein, which is essential for maintaining healthy muscle tissue.

The Role of the CAPN3 Gene

The CAPN3 gene encodes calpain-3, a calcium-dependent protease enzyme that plays a critical role in muscle function. This enzyme is primarily found in skeletal muscle, where it helps regulate the structure and stability of muscle fibers. When the CAPN3 gene functions correctly, it ensures that muscle cells can repair themselves and maintain their integrity during contraction and relaxation. However, when pathogenic variants occur in this gene, the production or function of calpain-3 can be severely impaired. This loss of function is the underlying cause of limb-girdle muscular dystrophy type 2A (LGMDR1). In this condition, the lack of functional calpain-3 leads to the progressive degeneration of muscles, particularly those around the hips and shoulders, which are known as the limb-girdle muscles.

Research Associations and Evidence Strength

Research strongly associates pathogenic variants in the CAPN3 gene with LGMDR1, an autosomal recessive disorder. This means that an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to manifest the condition. While some studies have explored whether certain variants might have a dominant effect, the primary clinical association for most CAPN3 variants remains recessive. The evidence for the pathogenicity of various CAPN3 variants is supported by clinical observations, muscle biopsy findings, and molecular studies that demonstrate a loss of calpain-3 activity. Because rs557164942 is extremely rare, clinical data is limited compared to more common variants. It is classified in databases as a variant of interest in the context of muscular dystrophy, and researchers continue to evaluate its specific impact on protein stability and muscle health.

Population Frequency and Distribution

The rs557164942 variant is classified as extremely rare in large-scale population databases like gnomAD, with a frequency of less than 0.001%. Because it is so uncommon, it is not a variant that the general population would typically encounter or carry. Its rarity means that it is not a standard marker used in routine health screenings. In the context of genetic counseling, the presence of such a rare variant is usually investigated only when there is a specific clinical suspicion of a muscular dystrophy or a family history of the condition. Its distribution does not appear to be concentrated in any single ethnic group, but rather appears sporadically in individuals undergoing diagnostic testing for unexplained muscle weakness.

What You Can and Cannot Do With This Information

Genetic information regarding rare variants like rs557164942 is intended for educational purposes and should not be used for self-diagnosis. If you have received a report mentioning this variant, it is important to understand that a single result does not constitute a medical diagnosis. Muscular dystrophies are complex conditions that require comprehensive clinical evaluation, including physical exams, blood tests, and potentially muscle biopsies or advanced imaging. You cannot use this information to predict your health outcomes or to make decisions about medical treatment. If you are concerned about your genetic status or family history, the most appropriate step is to consult with a board-certified genetic counselor or a neurologist specializing in neuromuscular disorders. They can provide context, interpret the results in light of your personal health history, and guide you through any necessary clinical follow-up.

Frequently asked questions

Sources & further reading